Overview

High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

Status:
Not yet recruiting
Trial end date:
2030-06-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare safety and efficacy between the aggressive treatment with combination of high-intensity statin and ezetimibe and the current standard lipid lowering treatment in asymptomatic patients with presence of coronary calcification.
Phase:
Phase 4
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Ezetimibe
Hydroxymethylglutaryl-CoA Reductase Inhibitors